Yongjing Liu

Yongjing Liu

Auto-generated profile, based on publicly available information

Yongjing Liu

Zhejiang Univ, Affiliated Hosp 1, Biomed Big Data Ctr, Sch Med, Hangzhou, Zhejiang, Peoples R China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2023 in Blood Advances
Verified
Journal Article
Open access
PDF file
HZHonghu Zhu
Honghu Zhu
YQYa-Zhen Qin
Ya-Zhen Qin
ZZZhang-Lin Zhang
Zhang-Lin Zhang
YLYong-Jing Liu
Yong-Jing Liu
LWLi-Jun Wen
Li-Jun Wen
SCSuning Chen
Suning Chen
Acute myeloid leukemia (AML) with retinoic acid receptor γ (RARG) rearrangement has clinical, morphologic, and immunophenotypic features similar to classic acute promyelocytic leukemia. However, AML with RARG rearrangement is insensitive to alltrans retinoic acid (ATRA) and arsenic trioxide (ATO) and carries a poor prognosis. We initiated a global cooperative study to define the clinicopathological features, genomic and transcriptomic landscape, and outcomes of AML with RARG rearrangements collected from 29 study groups/institutions worldwide. Thirty-four patients with AML with RARG rearrangements were identified. Bleeding or ecchymosis was present in 18 (54.5%) patients. Morphology diagnosed as M3 and M3v accounted for 73.5% and 26.5% of the cases, respectively. Immunophenotyping showed the following characteristics: positive for CD33, CD13, and MPO but negative for CD38, CD11b, CD34, and HLA-DR. Cytogenetics showed normal karyotype in 38% and t(11;12) in 26% of patients. The partner genes of RARG were diverse and included CPSF6, NUP98, HNRNPc, HNRNPm, PML, and NPM1. WT1- and NRAS/KRAS-mutations were common comutations. None of the 34 patients responded to ATRA and/or ATO. Death within 45 days from diagnosis occurred in 10 patients (∼29%). At the last follow-up, 23 patients had died, and the estimated 2-year cumulative incidence of relapse, event-free survival, and overall survival were 68.7%, 26.7%, and 33.5%, respectively. Unsupervised hierarchical clustering using RNA sequencing data from 201 patients with AML showed that 81.8% of the RARG fusion samples clustered together, suggesting a new molecular subtype. RARG rearrangement is a novel entity of AML that confers a poor prognosis. This study is registered with the Chinese Clinical Trial Registry (ChiCTR2200055810).

1 June 2020 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
PZPeijing Zhang
Peijing Zhang
YLYongjing Liu
Yongjing Liu
HCHongjun Chen
Hongjun Chen
XMXianwen Meng
Xianwen Meng
JXJitong Xue
Jitong Xue
Ming ChenMing Chen
Ming Chen
The recent discovery of circular RNAs (circRNAs) and characterization of their functional roles have opened a new avenue for understanding the biology of genomes. circRNAs have been implicated to play important roles in a variety of biological processes, but their precise functions remain largely elusive. Currently, a few approaches are available for novel circRNA prediction, but almost all these methods are intended for animal genomes. Considering that the major differences between the organization of plant and mammal genomes cannot be neglected, a plant-specific method is needed to enhance the validity of plant circRNA identification. In this study, we present CircPlant, an integrated tool for the exploration of plant circRNAs, potentially acting as competing endogenous RNAs (ceRNAs), and their potential functions. With the incorporation of several unique plant-specific criteria, CircPlant can accurately detect plant circRNAs from high-throughput RNA-seq data. Based on comparison tests on simulated and real RNA-seq datasets from Arabidopsis thaliana and Oryza sativa, we show that CircPlant outperforms all evaluated competing tools in both accuracy and efficiency. CircPlant is freely available at http://bis.zju.edu.cn/circplant.

5 January 2025 in EBioMedicine
Verified
Journal Article
Open access
ZLZhong Liu
Zhong Liu
BHBoqiang Hu
Boqiang Hu
TZTao Zeng
Tao Zeng
CYCuiping You
Cuiping You
NLNan Li
Nan Li
JHJinyan Huang
Jinyan Huang
Background Coronavirus disease-2019 (COVID-19), caused by SARS-CoV-2 virus infection, is characterized as a multisystem disease, potentially yielding multifaceted consequences on various organs at multiple levels. At the end of 2022, over 90% of the Chinese population was infected by SARS-CoV-2 within 35 days because of adjustments to epidemic prevention and control policies. This short-term change provides an unprecedented opportunity for comparative studies on COVID-19 infection among large populations. Methods In this study, the physical examination data of 136,713 people in the past three consecutive years was employed to study the impact of COVID-19. Standard physical examination data, comprising evaluations of nearly a hundred indicators, were investigated for a comprehensive assessment of COVID-19's effect on human health. Findings The results suggested that most indicators remained stable or changed within a permissible range after the COVID-19 outbreak in December 2022, but several specific indicators presented abnormal patterns of varying durations. There was an observed increase in the fraction of T-wave abnormalities during the outbreak, especially in people with chronic diseases such as hypertension, liver steatosis, and hyperglycemia. Interpretation These findings highlighted the impact of COVID-19 on cardiovascular health and its potential interaction with chronic diseases. Funding This work was supported by the National Key Research and Development Program of China (2019YFE0108100), the National Natural Science Foundation of China General Program (82270159, 82070147). Copyright (c) 2024 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

23 September 2024 in Computational Biology and Chemistry
Verified
Journal Article
Closed access
HDHeng Dong
Heng Dong
BMBaoshan Ma
Baoshan Ma
YMYangyang Meng
Yangyang Meng
YWYiming Wu
Yiming Wu
YLYongjing Liu
Yongjing Liu
JHJinyan Huang
Jinyan Huang